Delafruit consolidates its leadership in the baby food market

• Over the last two years, it has invested €12.5M in the expansion of production lines, modernising its facilities, and product and process innovation.
• The company, which will attend the largest international private label trade fair PLMA Amsterdam, has around 650 employees and produced about 300 million units of baby food products, juices and smoothies.
• Delafruit, a company owned by ProA Capital, is part of the B Corp community thanks to its compliance with the highest standards of social and environmental performance, transparency, corporate responsibility and good governance. 

The healthy baby food company Delafruit (formerly Go Fruselva), based in La Selva del Camp (Tarragona), closed the 2021 financial year with a total turnover of €108M. Thanks to last year's good performance, the company, which specialises in the development and co-manufacturing of baby food products, as well as healthy juices and smoothies in pouches, bottles and tubs for manufacturer and distributor brands, has consolidated its position as market leader.

One of the main factors behind Delafruit's sustained growth is its international activity, with 94% of its production volume destined for export. Specifically, it has close to 100 customers in 44 countries, with a special focus on Europe and Asia. Delafruit will therefore attend the largest international private label trade fair PLMA Amsterdam, which will start on the 31st of May.

Delafruit has a workforce of around 650 workers and a plant of more than 60,000 m2 in La Selva del Camp with 24 production lines that last year produced around 300 million units for third parties. The company holds all the certifications for food safety and quality, as well as those for groups with specific requirements, such as Kosher, Halal and vegan certifications, among others.
Committed to innovation in sustainability and health

Another of Delafruit's means for growth is the development of new products. To this end, the company has a team of 20 people dedicated to R&D&I with the main goal of identifying the different references demanded by its customers. It also works on joint projects with other companies to create new products.

Within the framework of this commitment, over the last two years, the company has invested around €12.5M in the modernisation of its facilities, the expansion of production lines, and R&D&I, among other projects. An investment of around €5M has been earmarked for innovation projects in 2022.

The company plays an active role in the development of external and internal research projects that enable it to expand its knowledge and then offer the results of its research to its customers. Delafruit is actively participating in eight R&D&I projects, in collaboration with entities such as the CDTI, and in 2022 expects approval to collaborate in six additional innovation projects presented during 2021. These are all focused on the development of new formats and the improvement of technologies and processes.

In 2021, Delafruit consolidated its commitment to innovation, sustainability and health, by developing healthy and nutritious products that contribute to improving diet quality and reducing the prevalence of preventable diseases with a high social impact related to food.

In addition to having R&D&I embedded in its DNA, the company is also strongly committed to sustainability. Proof of this is that it has recently become part of the B Corp community for its compliance with the highest standards in the field of social and environmental performance, transparency, corporate responsibility and good governance. The recognition of B Corp underscores Delafruit's commitment to sustainable development.

Read more: